Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3899400
Max Phase: Preclinical
Molecular Formula: C66H101N17O12
Molecular Weight: 1324.64
Molecule Type: Protein
Associated Items:
ID: ALA3899400
Max Phase: Preclinical
Molecular Formula: C66H101N17O12
Molecular Weight: 1324.64
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)O)C(C)C
Standard InChI: InChI=1S/C66H101N17O12/c1-38(2)54(63(92)75-40(5)56(85)79-53(36-43-37-74-47-22-10-9-20-45(43)47)61(90)77-48(23-12-15-31-68)58(87)78-50(65(94)95)24-13-16-32-69)83-64(93)55(39(3)4)82-62(91)52(35-42-26-28-44(84)29-27-42)81-60(89)51(34-41-18-7-6-8-19-41)80-59(88)49(25-17-33-73-66(71)72)76-57(86)46(70)21-11-14-30-67/h6-10,18-20,22,26-29,37-40,46,48-55,74,84H,11-17,21,23-25,30-36,67-70H2,1-5H3,(H,75,92)(H,76,86)(H,77,90)(H,78,87)(H,79,85)(H,80,88)(H,81,89)(H,82,91)(H,83,93)(H,94,95)(H4,71,72,73)/t40-,46+,48-,49-,50+,51-,52-,53-,54-,55-/m0/s1
Standard InChI Key: BGBONDNYYNHOHA-DZYYPJIBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1324.64 | Molecular Weight (Monoisotopic): 1323.7816 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Denèfle T, Boullet H, Herbi L, Newton C, Martinez-Torres AC, Guez A, Pramil E, Quiney C, Pourcelot M, Levasseur MD, Lardé E, Moumné R, Ogi FX, Grondin P, Merle-Beral H, Lequin O, Susin SA, Karoyan P.. (2016) Thrombospondin-1 Mimetic Agonist Peptides Induce Selective Death in Tumor Cells: Design, Synthesis, and Structure-Activity Relationship Studies., 59 (18): [PMID:27526615] [10.1021/acs.jmedchem.6b00781] |
Source(1):